DIGITAL THERAPEUTICS FOR ANXIETY AND DEPRESSION: A STRUCTURED REVIEW OF CLINICAL EVIDENCE, REGULATORY FRAMEWORKS, AND ACCESS DISPARITIES
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6267Keywords:
Digital Therapeutics, Anxiety Disorders, Depressive Disorders, Regulatory Frameworks, Health Equity, Software as a Medical DeviceAbstract
Background: The integration of Digital Therapeutics (DTx) into psychiatric care represents a paradigm shift in the management of anxiety and depression. With the continuous technological advancement of Software as a Medical Device (SaMD), its potential to alleviate shortages in psychiatric care is facing rigorous evaluation. As a result, ongoing studies aim to verify whether these technologies deliver genuine medical improvements, while simultaneously exploring the structural hurdles of deploying them within traditional clinical settings.
Objective: This structured review evaluates the intersection of clinical evidence for DTx in treating Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD) with existing regulatory frameworks and socioeconomic barriers to equitable access.
Methodology: An investigative sweep of the PubMed/MEDLINE and Google Scholar databases was executed to identify literature published from 2018 to 2026. Inclusion criteria focused on peer-reviewed RCTs and policy analyses of evidence-based DTx platforms. The assembled data underwent systematic organization via a thematic approach, with material being classified into three distinct categories: clinical efficacy, regulatory limitations, and accessibility equity.
Results: Findings indicate that while AI-driven CBT and chatbot-delivered interventions demonstrate significant symptom reduction with moderate-to-high effect sizes, their long-term efficacy is moderated by user engagement patterns. Regulatory analysis reveals a fragmentation between the US FDA and European DiGA pathways, complicating global reimbursement. Furthermore, structural disparities—driven by the "digital divide" and low technological literacy—persistently limit the reach of these interventions among underserved populations.
Conclusion: Digital interventions present an easily expandable mechanism for combating global psychiatric shortages; however, inconsistent legal guidelines and socioeconomic barriers heavily restrict their medical utility. Subsequent academic efforts need to emphasize multidimensional adoption models to prevent these technological advancements from worsening present-day medical inequalities.
References
Baumel, A., Muench, F., Edan, S., & Kane, J. M. (2019). Objective user engagement with mental health apps: Systematic search and panel-based usage analysis. Journal of Medical Internet Research, 21(9), e14567. https://doi.org/10.2196/14567
Chang, J. E., Lai, A. Y., Gupta, A., Nguyen, A. M., Berry, C. A., & Shelley, D. R. (2021). Rapid transition to telehealth and the digital divide: Implications for primary care access and equity in a post-COVID era. The Milbank Quarterly, 99(2), 340–368. https://doi.org/10.1111/1468-0009.12509
Fitzpatrick, K. K., Darcy, A., & Vierhile, M. (2017). Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): A randomized controlled trial. JMIR Mental Health, 4(2), e19. https://doi.org/10.2196/mental.7785
Fulmer, R., Joerin, A., Gentile, B., Lakerink, L., & Rauws, M. (2018). Using psychological artificial intelligence (Tess) to relieve symptoms of depression and anxiety: Randomized controlled trial. JMIR Mental Health, 5(4), e64. https://doi.org/10.2196/mental.9782
Gerke, S., Stern, A. D., & Minssen, T. (2020). Germany’s digital health reforms in the MDR era: Lessons and policy implications from the Digitale Versorgung Gesetz. npj Digital Medicine, 3(1), 74. https://doi.org/10.1038/s41746-020-0306-7
Graham, A. K., Lattie, E. G., Powell, B. J., Lyon, A. R., Smith, J. D., Schueller, S. M., Stadnick, N. A., Brown, C. H., & Mohr, D. C. (2020). Implementation strategies for digital mental health interventions in health care settings. American Psychologist, 75(8), 1080–1092. https://doi.org/10.1037/amp0000686
Lattie, E. G., Stiles-Shields, C., & Graham, A. K. (2022). An overview of and recommendations for more accessible digital mental health interventions. Nature Reviews Psychology, 1(2), 87–100. https://doi.org/10.1038/s44159-021-00003-1
Linardon, J., Cuijpers, P., Carlbring, P., Messer, M., & Fuller-Tyszkiewicz, M. (2019). The efficacy of app-supported smartphone interventions for mental health problems: A meta-analysis of randomized controlled trials. World Psychiatry, 18(3), 325–336. https://doi.org/10.1002/wps.20673
Mohr, D. C., Azocar, F., Bertagnolli, A., Choudhury, T., Devine, J., Duffecy, J., Firth, J., Haley, A. D., Kaiser, S. M., Kaziunas, E., Lattie, E. G., Lenze, E. J., Nguyen, T., Nyer, M., Ohashi, K., Prociow, P., Ross, S., Schueller, S. M., Sherrill, J., … Wisniewski, H. (2021). Banbury Forum consensus statement on the path forward for digital mental health treatment. Psychiatric Services, 72(6), 677–683. https://doi.org/10.1176/appi.ps.202000561
Nakayama, L. F., Binotti, W. W., Link Woite, N., Fernandes, C. O., Alfonso, P. G., Celi, L. A., & Regatieri, C. V. (2023). The digital divide in Brazil and barriers to telehealth and equal digital health care: Analysis of internet access using publicly available data. Journal of Medical Internet Research, 25, e42483. https://doi.org/10.2196/42483
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Patel, V., Saxena, S., Lund, C., Thornicroft, G., Baingana, F., Bolton, P., Chisholm, D., Collins, P. Y., Cooper, J. L., Eaton, J., Hermann, H., Herzallah, M., Huang, Y., Jordans, M. J. D., Kleinman, A., Medina-Mora, M. E., Morgan, E., Niaz, U., Omigbodun, O., … UnÜtzer, J. (2018). The Lancet Commission on global mental health and sustainable development. The Lancet, 392(10157), 1553–1598. https://doi.org/10.1016/S0140-6736(18)31612-X
Price-Haywood, E. G., Arnold, C., Harden-Barrios, J., & Davis, T. (2023). Stop the divide: Facilitators and barriers to uptake of digital health interventions among socially disadvantaged populations. The Ochsner Journal, 23(1), 34–42. https://doi.org/10.31486/toj.22.0101
Ramos, G., & Chavira, D. A. (2022). Use of technology to provide mental health care for racial and ethnic minoritized populations: Evidence, promise, and challenges. Cognitive and Behavioral Practice, 53(1), 15-30. https://doi.org/10.1016/j.cbpra.2020.09.003
Rikard, R. V., Thompson, M. S., McKinney, J., & Beauchamp, A. (2021). Examining health literacy disparities in the United States: A third look at the National Assessment of Adult Literacy (NAAL). BMC Public Health, 21(1), 1–11. https://doi.org/10.1186/s12889-021-10661-6
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., Bang-Jensen, B. L., Bertolacci, G. J., Bloom, S. S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., … Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700–1712. https://doi.org/10.1016/S0140-6736(21)02143-7
Schueller, S. M., Neary, M., O'Loughlin, K., & Adkins, E. C. (2018). Discovery of and interest in health apps among those with mental health needs: Survey and focus group study. Journal of Medical Internet Research, 20(6), e10141. https://doi.org/10.2196/10141
Sinha, C., Kadambi, A., Patnaik, S., Muke, S., John, T., Kamble, P., ... & Ransing, R. (2022). Real-world evidence of an AI conversational agent (Wysa) on depressive symptoms: Retrospective longitudinal analysis. JMIR Formative Research, 6(12), e41392. https://doi.org/10.2196/41392
Thomas, J., & Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Medical Research Methodology, 8(1), 45. https://doi.org/10.1186/1471-2288-8-45
Torous, J., & Hsin, H. (2018). Empowering the digital therapeutic relationship: Virtual clinics for digital health interventions. npj Digital Medicine, 1(1), 16. https://doi.org/10.1038/s41746-018-0028-2
Torous, J., Lipschitz, J., Ng, M., & Firth, J. (2020). Dropout rates in clinical trials of smartphone apps for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 263, 413–419. https://doi.org/10.1016/j.jad.2019.11.167
Torous, J., Bucci, S., Bell, I. H., Kessing, L. V., Faurholt-Jepsen, M., Whelan, P., Carvalho, A. F., Keshavan, M., Linardon, J., & Firth, J. (2021). The growing field of digital psychiatry: Current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry, 20(3), 318–335. https://doi.org/10.1002/wps.20883
Vaidyam, A. N., Wisniewski, H., Halamka, J. D., Kashavan, M. S., & Torous, J. B. (2019). Chatbots and conversational agents in mental health: A review of the psychiatric landscape. The Canadian Journal of Psychiatry, 64(7), 456–464. https://doi.org/10.1177/0706743719828977
Watson, A., Chapman, R., Shafai, G., & Maricich, Y. A. (2023). FDA regulations and prescription digital therapeutics: Evolving with the technologies they regulate. Frontiers in Digital Health, 5, 1086219. https://doi.org/10.3389/fdgth.2023.1086219
Woehl, A., Bhatt, A., & Bhatt, A. (2022). Woebot – AI chatbot and its clinical implications in mental health: A literature review. Cureus, 14(3), e23425. https://doi.org/10.7759/cureus.23425
World Health Organization. (2022a). World mental health report: Transforming mental health for all. World Health Organization. https://www.who.int/publications/i/item/9789240049338.
World Health Organization. (2022b). COVID-19 pandemic triggers 25% increase in the prevalence of anxiety and depression worldwide. WHO News Release. https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide.
Xia, S. H., Narayanan, M. M., Swamy, V., & Franson, K. (2025). Therapeutic evaluation and utilization analysis of mental health prescription digital therapeutics within the current regulatory landscape. Pharmacy, 13(1), 19. https://doi.org/10.3390/pharmacy13010019
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Maryan Liasota, Michalina Justyna Kozłowska, Krzysztof Konopka, Maciej Kamil Majchrzak , Faustyna Magdalena Kołodziej, Alicja Kwiatkowska , Jakub Juskowiak , Mateusz Lis , Zuzanna Julia Komin, Eliza Zofia Kabat
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
